Filters
Users of combined oral contraceptives (COCs) are at increased risk of emotional eating, as reported in a study.
The use of buprenorphine helps prolong the antisuicidal benefits derived from treatment with ketamine in patients with major depressive disorder (MDD), suggests a study.
Complex interactions between glutamatergic, opioidergic, and GABAergic systems modulate the antidepressant effects of ketamine on cerebral blood flow (CBF) in patients with major depressive disorder (MDD), suggests a recent study.
A recent Delphi-based expert consensus has released guidelines on preventing relapse after a successful electroconvulsive therapy (ECT) for patients with major depressive disorder (MDD).
A perceived lack of workplace support and less time residing in Singapore appear to contribute to the development of burnout among Allied Health Professionals (AHPs) in the post-COVID era, suggests a local study.
Exposure to several glucose-lowering drugs appears to have a protective effect on the risk of depression in individuals with type 2 diabetes (T2D), according to a population-based cohort study in Hong Kong.
In the treatment of individuals with cocaine use disorder, the use of psilocybin may help improve abstinence rates and reduce the risk of cocaine lapse over time, as shown in a study.
Children who have been maltreated require care that routine surveillance practice do not fully meet, according to a Singapore study. Moreover, these kids are at risk of shirking their hospital appointments.
A significant proportion of rheumatology patients have been diagnosed with anxiety, depression, or fibromyalgia (FM), reveals a study, noting the importance of including screening for clinical decisions at all routine encounters.
The phase 3 trial of the selective dopamine D1 receptor antagonist ecopipam has demonstrated maintenace of tic suppression for up to 24 weeks and reduction in the risk of relapse of 50 percent in children with Tourette syndrome.
